Search - tctmd.com

Displaying 581 - 600 of 606

Sort: Relevancy | Date

News Daily News

Boston Scientific Announces Fix for Lotus Edge TAVR Device Following Implantation ‘Pause’

L.A. McKeown

January 11, 2017

News Daily News

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

Todd Neale

January 06, 2017

Presentation

Thirty-Day Readmissions After TAVR

Presenter: D. Kolte

January 06, 2017

Presentation

Transcatheter Valve-in-Ring Implantation for Residual or Recurrent Tricuspid Valve Dysfunction After Prior Surgical Repair

Presenter: J. Aboulhosn

January 05, 2017

News Daily News

Transcatheter Valve-in-Ring for Failed Tricuspid Repair: New Hope for Patients With Few Options

Caitlin E. Cox

January 05, 2017

News Daily News

New TAVR Guidance Aims to Ease Evaluation, Management of Patients With Aortic Stenosis

Todd Neale

January 05, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

Presentation

Apixaban in Patients With Atrial Fibrillation After TAVR

Presenter: J. Seeger

January 03, 2017

Presentation

Complications of Structural Heart Disease Intervention

Presenter: George Hanzel

October 31, 2016

Presentation CCVVC 2016

Choice of Sapien vs CoreValve TAVR

Presenter: Eduardo J. de Marchena

June 16, 2016

Presentation CCVVC 2016

Subclinical Leaflet Thrombosis Post-TAVR

Presenter: Gian Paolo Ussia

June 16, 2016

Presentation ACC 2016

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-Risk Patients: A Propensity Score Analysis

Presenter: Vinod Thourani

April 01, 2016

Presentation

TAVR Year in Review: The Good the Bad and Ugly

Presenter: Eduardo de Marchena

January 29, 2016

Presentation

Quality-of-life Outcomes After TAVR in an Unselected Population

Presenter: Suzanne Arnold

February 06, 0017

Partner Content

What You Need to Know About Cerebral Embolic Protection (CEP)

June 29, 2017

CME

TAVR Evolves: Are You and the Heart Team Ready?

Partner Content

Registration: TAVR Evolves: Are You and the Heart Team Ready?

July 7, 2017

Partner Content

Registration: Expanded TAVR Indications: Post TCT 2016

February 1, 2017

Advertisement

Boston Scientific Announces Fix for Lotus Edge TAVR Device Following Implantation ‘Pause’

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

Thirty-Day Readmissions After TAVR

Transcatheter Valve-in-Ring Implantation for Residual or Recurrent Tricuspid Valve Dysfunction After Prior Surgical Repair

Transcatheter Valve-in-Ring for Failed Tricuspid Repair: New Hope for Patients With Few Options

New TAVR Guidance Aims to Ease Evaluation, Management of Patients With Aortic Stenosis

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Apixaban in Patients With Atrial Fibrillation After TAVR

Complications of Structural Heart Disease Intervention

Choice of Sapien vs CoreValve TAVR

Subclinical Leaflet Thrombosis Post-TAVR

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-Risk Patients: A Propensity Score Analysis

TAVR Year in Review: The Good the Bad and Ugly

Quality-of-life Outcomes After TAVR in an Unselected Population

What You Need to Know About Cerebral Embolic Protection (CEP)

TAVR Evolves: Are You and the Heart Team Ready?

Registration: TAVR Evolves: Are You and the Heart Team Ready?

Registration: Expanded TAVR Indications: Post TCT 2016

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content